Medicenna Therapeutics Corp. Number Of Share Options Granted In Share-based Payment Arrangement
Medicenna Therapeutics Corp. (MDNAF) reported Number Of Share Options Granted In Share-based Payment Arrangement of 129071300.00% for the 12-month period ending 2023-03-31, per its 20-F filed 2023-06-27.
Discontinued › Notes › Compensation Related Costs
ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement · last filed 2023-06-27
| Period end | Number Of Share Options Granted In Share-based Payment Arrangement 12 month |
|---|---|
| 2023-03-31 | 129071300.00% 20-F · filed 2023-06-27 |
| 2022-03-31 | 109705600.00% 20-F · filed 2023-06-27 |
| 2021-03-31 | 45008400.00% 20-F · filed 2023-06-27 |
| 2020-03-31 | 123000000.00% 20-F · filed 2022-06-22 |
| 2019-03-31 | 137500000.00% 40-F · filed 2021-05-28 |